Colleen Delaney
Chief Tech/Sci/R&D Officer at COEPTIS THERAPEUTICS HOLDINGS, INC.
Net worth: - $ as of 30/05/2024
Colleen Delaney active positions
| Companies | Position | Start | End |
|---|---|---|---|
| VICAPSYS LIFE SCIENCES, INC. | Director/Board Member | 21/09/2022 | - |
| COEPTIS THERAPEUTICS HOLDINGS, INC. | Chief Tech/Sci/R&D Officer | 29/08/2023 | - |
| American Society for Blood & Marrow Transplantation | Director/Board Member | - | - |
Deverra Therapeutics, Inc.
 Deverra Therapeutics, Inc. BiotechnologyHealth Technology Deverra Therapeutics, Inc. engages in the development of platform technology for the generation of off-the-shelf allogeneic cellular immunotherapies. It offers a notch-mediated cell expansion platform for the production of progenitor blood and immune cells for clinical application. The company is headquartered in Seattle, WA. | Chief Tech/Sci/R&D Officer | - | - |
| Founder | - | - | |
University of Washington
 University of Washington Other Consumer ServicesConsumer Services University of Washington functions as a College/University. The company is headquartered in Seattle, WA. | Corporate Officer/Principal | - | - |
Career history of Colleen Delaney
Former positions of Colleen Delaney
| Companies | Position | Start | End |
|---|---|---|---|
Fred Hutchinson Cancer Research Center
 Fred Hutchinson Cancer Research Center Miscellaneous Commercial ServicesCommercial Services Fred Hutchinson Cancer Research Center is a non-profit organization which provides research and testing services. The company was founded in 1965 and is headquartered in Seattle, WA. | Corporate Officer/Principal | - | - |
Fred Hutchinson Cancer Center
 Fred Hutchinson Cancer Center Hospital/Nursing ManagementHealth Services Fred Hutchinson Cancer Center is a research and patient care institution that is committed to eradicating cancer and related diseases as causes of human suffering and death. The center conducts research and provides patient care of the highest standards to improve the prevention and treatment of cancer and related diseases. | Corporate Officer/Principal | - | - |
Nohla Therapeutics, Inc.
 Nohla Therapeutics, Inc. BiotechnologyHealth Technology Nohla Therapeutics, Inc. developed cellular therapies for hematological disorders. The firm's products used without the need for HLA matching and promote hematopoietic recovery in patients at risk for neutropenia after intensive chemotherapy and/or radiation treatment for critical diseases. The company was founded by Colleen Delaney and was headquartered in Seattle, WA. | Chief Tech/Sci/R&D Officer | - | - |
| Founder | - | - |
Training of Colleen Delaney
| University of Oxford | Graduate Degree |
| Harvard Medical School | Doctorate Degree |
Statistics
International
| United States | 10 |
| United Kingdom | 2 |
Operational
| Chief Tech/Sci/R&D Officer | 3 |
| Corporate Officer/Principal | 3 |
| Founder | 2 |
Sectoral
| Health Technology | 5 |
| Consumer Services | 4 |
| Commercial Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 2 |
|---|---|
| VICAPSYS LIFE SCIENCES, INC. | Health Technology |
| COEPTIS THERAPEUTICS HOLDINGS, INC. | Health Technology |
| Private companies | 5 |
|---|---|
Fred Hutchinson Cancer Research Center
Fred Hutchinson Cancer Research Center Miscellaneous Commercial ServicesCommercial Services Fred Hutchinson Cancer Research Center is a non-profit organization which provides research and testing services. The company was founded in 1965 and is headquartered in Seattle, WA. | Commercial Services |
| American Society for Blood & Marrow Transplantation | |
Nohla Therapeutics, Inc.
Nohla Therapeutics, Inc. BiotechnologyHealth Technology Nohla Therapeutics, Inc. developed cellular therapies for hematological disorders. The firm's products used without the need for HLA matching and promote hematopoietic recovery in patients at risk for neutropenia after intensive chemotherapy and/or radiation treatment for critical diseases. The company was founded by Colleen Delaney and was headquartered in Seattle, WA. | Health Technology |
Deverra Therapeutics, Inc.
Deverra Therapeutics, Inc. BiotechnologyHealth Technology Deverra Therapeutics, Inc. engages in the development of platform technology for the generation of off-the-shelf allogeneic cellular immunotherapies. It offers a notch-mediated cell expansion platform for the production of progenitor blood and immune cells for clinical application. The company is headquartered in Seattle, WA. | Health Technology |
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center Hospital/Nursing ManagementHealth Services Fred Hutchinson Cancer Center is a research and patient care institution that is committed to eradicating cancer and related diseases as causes of human suffering and death. The center conducts research and provides patient care of the highest standards to improve the prevention and treatment of cancer and related diseases. | Health Services |
- Stock Market
- Insiders
- Colleen Delaney
- Experience